Resultados de la búsqueda

Pérez-Medina C, Fisher EA, Fayad ZA, Mulder WJM, Teunissen AJP. Radiolabeling lipoproteins to study and manage disease. Eur J Nucl Med Mol Imaging (2025) 52:4717-4734.
Link to the full text in Repisalud

Nogales P; Velasco C; González-Cintado L; Sharysh D; Mota-Cobián A; Torroja C; Morales-Cano D; Mota R; Benguría A; Izquierdo-Serrano R; Dopazo A; Sánchez-Cabo F; España S; Carramolino L; Mateo J; Bentzon J. 18FDG-pet imaging reveals glycolytic activity as a marker of atherosclerotic disease activity Atherosclerosis (2025) 407

Nogales P, Velasco C, González-Cintado L, Sharysh D, Mota-Cobián A, Izquierdo-Serrano R, Torroja C, Del Rio-Aledo D, Morales-Cano D, Mota RA, Benguría A, Dopazo A, Sánchez-Cabo F, Vázquez J, España S, Carramolino L, Mateo J, Bentzon JF. Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET. Sci Transl Med (2025) 17:eado6467
Link to the full text in Repisalud

Bernal A, Hamid A, Grao-Roldán C, Scarpa A, Sánchez I, Nicolás-Ávila JÁ, Pena-Couso L, Yaghmour MH, Benguría A, Rosado A, Sánchez-García L, Torroja C, Dopazo A, Sánchez-Cabo F, Hidalgo A, Senders ML, van Leent MMT, Seep L, Hasenauer J, Placek K, Thiele C, Netea MG, Mulder WJM, Riksen NP, Pérez-Medina C. HDL-associated phosphatidylserine blunts myeloid activation and protects from atherosclerosis. bioRxiv [Preprint]. bioRxiv (2025) Nov 30 [Epub ahead of print]
bioRxiv [Preprint]

Toner YC, Prévot G, van Leent MMT, Munitz J, Oosterwijk R, Verschuur AVD, van Elsas Y, Peric V, Maas RJF, Ranzenigo A, Morla-Folch J, Wang W, Umali M, de Dreu A, Fernandes JC, Sullivan NAT, Maier A, Mason C, Reiner T, Fayad ZA, Mulder WJM, Teunissen AJP, Pérez-Medina C. Macrophage PET imaging in mouse models of cardiovascular disease and cancer with an apolipoprotein-inspired radiotracer. Npj Imaging (2024) 2:12
Link to the full text in Repisalud

Toner YC, Ghotbi AA, Naidu S, Sakurai K, van Leent MMT, Jordan S, Ordikhani F, Amadori L, Sofias AM, Fisher EL, Maier A, Sullivan N, Munitz J, Senders ML, Mason C, Reiner T, Soultanidis G, Tarkin JM, Rudd JHF, Giannarelli C, Ochando J, Pérez-Medina C, Kjaer A, Mulder WJM, Fayad ZA, Calcagno C. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation. Sci Rep (2022) 12
Link to the full text in Repisalud

Bernal A, Calcagno C, Mulder WJM, Pérez-Medina C Imaging-guided nanomedicine development CURR OPIN CHEM BIOL (2021) 63:78-85

Teunissen AJP, van Leent MMT, Prevot G, Brechbuhl EES, Pérez-Medina C, Duivenvoorden R, Fayad ZA, Mulder WJM Targeting Trained Innate Immunity With Nanobiologics to Treat Cardiovascular Disease Arterioscler Thromb Vasc Biol (2021) 41:1839-50

de Lucas B, Pérez LM, Bernal A, Gálvez BG Application of low-intensity pulsed therapeutic ultrasound on mesenchymal precursors does not affect their cell properties PLoS One (2021) 16:e0246261

van Leent MMT, Meerwaldt AE, Berchouchi A, Toner YC, Burnett ME, Klein ED, Verschuur AVD, Nauta SA, Munitz J, Prévot G, van Leeuwen EM, Ordikhani F, Mourits VP, Calcagno C, Robson PM, Soultanidis G, Reiner T, Joosten RRM, Friedrich H, Madsen JC, Kluza E, van der Meel R, Joosten LAB, Netea MG, Ochando J, Fayad ZA, Pérez-Medina C, Mulder WJM, Teunissen AJP A modular approach toward producing nanotherapeutics targeting the innate immune system Sci Adv (2021) 7:eabe7853